Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Duchenne muscular dystrophy treatment
market5 mentionslast seen Nov 5, 2026
Treatment of Duchenne muscular dystrophy.
Relationships 4
- (Z)-endoxifenapplies toDuchenne muscular dystrophy treatment99% confidence2 sources
- PBGENE-DMDapplies toDuchenne muscular dystrophy treatment95% confidence1 source
- ENTR-601-45applies toDuchenne muscular dystrophy treatment94% confidence1 source
- ifetrobanapplies toDuchenne muscular dystrophy treatment90% confidence1 source
Relationship
(Z)-endoxifenapplies toDuchenne muscular dystrophy treatment
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGAROct 9, 2026ATOSSA THERAPEUTICS, INC. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 3.03: Material Modifications to Rights of Security Holders; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
(Z)-endoxifen for the treatment of Duchenne muscular dystrophy
- filingSEC EDGARSep 29, 2026ATOSSA THERAPEUTICS, INC. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
FDA Orphan Drug Designation for (Z)-endoxifen for Duchenne muscular dystrophy